Hemostatic product transfusions and adverse outcomes: focus on point-of-care testing to reduce transfusion need.
von Kier
S
S
Department of Anaesthesia, Royal Brompton and Harefield NHS Trust, Harefield Hospital, UK.
Smith
A
A
D001777:Blood Coagulation; D016913:Blood Component Transfusion / Q000009:adverse effects; D001792:Blood Platelets / Q000502:physiology; D006348:Cardiac Surgical Procedures; D006801:Humans; D010314:Partial Thromboplastin Time; D019095:Point-of-Care Systems; D011517:Prothrombin Time